openPR Logo
Press release

Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players, Industry Trends & Forecast

04-08-2019 12:23 PM CET | IT, New Media & Software

Press release from: Exosome Technologies

Exosome Technologies: Recent Surge in R&D with Capricor, Codiak

Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players, explores the application of exosome technologies within the pharmaceutical and healthcare industries. Exosomes are small cell-derived vesicles that are abundant in bodily fluids, including blood, urine and cerebrospinal fluid as well as in in vitro cell culture.

These vesicles are being used in a variety of therapeutic applications, including as therapeutic biomarkers, drug delivery systems and therapies in their own right. Research within this area remains in the nascent stages, although a number of clinical trials have been registered within the field. Exosomes have several diverse therapeutic applications, largely centering on stem cell and gene therapy. Exosomes have been identified as endogenous carriers of RNA within the body, allowing for the intercellular transportation of genetic material to target cells.

Request to view Sample of Exosome Technologies for more Professional & Technical Insights: https://www.researchmoz.us/enquiry.php?type=S&repid=1935556

As such, developers have worked to engineer exosomes for the delivery of therapeutic miRNA and siRNA-based gene therapies. As RNA is highly unstable within the body, a number of different biologic vector systems have been developed to enhance their transport within the circulation, including viruses and liposomes. Similarly, exosomes derived from stem cells have also been identified for their therapeutic applications, particularly in the treatment of cancer and cardiovascular disease. Exosome technologies offer several advantages over existing biologic-based drug delivery systems.

They have a long circulatory half-life as a result of their high stability and ability to avoid breakdown by the mononuclear phagocyte system and reticuloendothelial systems. Moreover, exosomes have several functional properties that favor their use in therapeutic delivery. Exosomes can be engineered to incorporate targeting ligands, allowing them to deliver cargo selectively to cells. Their small size allows them to penetrate the blood-brain barrier for the delivery of central nervous system therapies, whereas in cancer they can accumulate within the tumor via enhanced permeability and retention effects.

Get Assistance on Exosome Technologies Market at: https://www.researchmoz.us/enquiry.php?type=E&repid=1935556

Finally, clinical trials have shown relatively large-scale production to be possible and indicate that exosome therapies can be safely administered to humans. Additionally, exosomes are being investigated for their potential as prognostic and diagnostic biomarkers for several different disease indications. Exosomes make good candidates for biomarker research because of two unique characteristics: their presence in various accessible bodily fluids, and their resemblance to their parent cells of origin. R&D in exosome technologies has increased markedly in recent years. This report provides detailed information on the various healthcare applications of exosomes, and assesses the pipeline, clinical trial and company landscapes.

Scope

What are the features of the exosome lifecycle?
How are therapeutic exosomes prepared?
How do exosome therapies in development differ in terms of stage of development, molecule type and therapy area?
Which companies are investing in exosome technologies?
How many clinical trials investigate exosomes as biomarkers, therapeutics and vectors?

Reasons to buy

Develop a comprehensive understanding of exosome technologies and their potential for use within the healthcare sector.
Analyze the pipeline landscape and gain insight into the key companies investing in exosomes technologies.
Identify trends in interventional and observational clinical trials relevant to exosomes.

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website: https://www.researchmoz.us
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ bit.ly/1TBmnVG
Blog: https://blogreportstudy.blogspot.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players, Industry Trends & Forecast here

News-ID: 1692711 • Views:

More Releases from Exosome Technologies

New Study On Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players
New Study On Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and …
Researchmoz added Most up-to-date research on "New Study On Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players" to its huge collection of research reports. GBI Research’s latest report, Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players, explores the application of exosome technologies within the pharmaceutical and healthcare industries. Exosomes are small cell-derived vesicles that are abundant in

More Releases for Exosomes

Exosomes Market to Witness Comprehensive Growth by 2030
Acumen Research and Consulting has announced the addition of the "Exosomes Market" report to their offering. The Exosomes Market Report 2030 is an in depth study analyzing the current state of the Exosomes Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Exosomes Market provides analysis of China market covering the industry trends, recent developments in the market
Global Exosomes Market Size - Forecast to 2026
As per the research conducted by GME, the Exosomes Market is estimated to be valued at USD 1.82 Billion in 2021 and is projected to reach USD 5.58 Billion by 2026 at a CAGR of 25.12%. The expanding preponderance of cancer, technological breakthroughs in exosome isolation & analytical procedures, and enhancing the innovative capabilities of exosomes are among the considerations supporting global exosomes market advancement. Browse 151 Market Data Tables
Exosomes News: Creative Biolabs Introduces Exosome Purification Services for Car …
As exosomes can transmit the information of donor cells to recipient cells through the proteins, mRNA, miRNA carried by them, thus to realize the information and material exchange between cells, they have been a hot topic recently as being used as a drug carrier to transport drugs. "Future research may focus on how to improve the cargo loading of exosomes," said the senior scientist from Creative Biolabs, “at present, some
Exosomes Market Growth Trends, Factors and Comprehensive Analysis by 2027
Exosomes market is expected to grow during the forecast period owing to the key driving factors such as rising healthcare expenditure, increase prevalence of cancer, raising emphasis on early diagnosis of cancer, increase oncology research, awareness related to healthcare and others. In addition, various players in the emerging market have strong pipeline product and high potential which are anticipated to create several growth opportunities for the market during the forecast
Exosomes Market by Growth Analysis 2019 | Fujifilm, Thermo Fisher Scientific, Da …
The Global Exosomes market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Exosomes Market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global Exosomes market.
Exosomes Market 2018 Trend, Segmentation and Opportunities Forecast To 2025
This report studies the global Exosomes market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Exosomes market by companies, region, type and end-use industry. Get Free Sample Copy of Report at https://www.researchformarkets.com/sample/global-exosomes-market-107652 This report focuses on the global top players, covered Fujifilm, Danaher, Lonza, Illumina, Inc., Thermo Fisher Scientific, Qiagen, Takara Bio Company, Malvern Instruments, Hitachi Chemical Diagnostics, Miltenyi Biotec, Diagenode, Novus Biologicals, New